MedTrace Logo

Non-invasive Methods and Surgical Risk Stratification in Cirrhotics Undergoing Elective Extrahepatic Surgery

NCT04615091 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 250

Last updated 2020-11-04

No results posted yet for this study

Summary

The ELASTO-SURGERY study aims to evaluate the prognostic role of portal hypertension evaluated by non-invasive methods in predicting post-operative morbidity (at 90 days) and mortality (at 365 days) in patients with advanced chronic liver disease undergoing elective extrahepatic surgery.

Conditions

  • Advanced Chronic Liver Disease
  • Surgery--Complications

Sponsors & Collaborators

  • Azienda Ospedaliera Universitaria Integrata Verona

    lead OTHER

Principal Investigators

  • ANTONIO COLECCHIA, MD · Azienda Ospedaliera Universitaria Integrata Verona

  • DAVIDE FESTI, MD · University of Bologna

  • GIOVANNI MARASCO, MD; PhD · University of Bologna

  • CATERINA CUSUMANO, MD · Azienda Ospedaliera Universitaria Integrata Verona

  • KAMELA GJINI · Azienda Ospedaliera Universitaria Integrata Verona

  • FEDERICO RAVAIOLI, MD · University of Bologna

  • ELTON DAJTI, MD · University of Bologna

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-08-30
Primary Completion
2021-10-31
Completion
2022-08-31

Countries

  • United States
  • Austria
  • Canada
  • Denmark
  • France
  • Germany
  • Hong Kong
  • Italy
  • South Korea
  • Spain
  • Switzerland
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04615091 on ClinicalTrials.gov